Nothing Special   »   [go: up one dir, main page]

USB402657I5 - - Google Patents

Info

Publication number
USB402657I5
USB402657I5 US40265773A USB402657I5 US B402657 I5 USB402657 I5 US B402657I5 US 40265773 A US40265773 A US 40265773A US B402657 I5 USB402657 I5 US B402657I5
Authority
US
United States
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to US05/402,657 priority Critical patent/US4013665A/en
Priority to FR7432265A priority patent/FR2245369B1/fr
Priority to ZA00746138A priority patent/ZA746138B/xx
Priority to BE148952A priority patent/BE820400A/xx
Priority to FI2815/74A priority patent/FI57414C/fi
Priority to NO743528A priority patent/NO143223C/no
Priority to AU73798/74A priority patent/AU492448B2/en
Priority to CY1087A priority patent/CY1087A/xx
Priority to GB42353/74A priority patent/GB1488692A/en
Priority to CH1316374A priority patent/CH621552A5/de
Priority to CA210,304A priority patent/CA1032538A/en
Priority to ES430554A priority patent/ES430554A1/es
Priority to SE7412275A priority patent/SE419760B/xx
Priority to DK516274A priority patent/DK516274A/da
Priority to JP49112386A priority patent/JPS582948B2/ja
Priority to NL7412959A priority patent/NL7412959A/xx
Priority to DE19742446821 priority patent/DE2446821A1/de
Publication of USB402657I5 publication Critical patent/USB402657I5/en
Application granted granted Critical
Publication of US4013665A publication Critical patent/US4013665A/en
Priority to CH1180A priority patent/CH619712A5/de
Priority to CH484580A priority patent/CH622793A5/de
Priority to KE3086A priority patent/KE3086A/xx
Priority to HK593/80A priority patent/HK59380A/xx
Priority to MY219/81A priority patent/MY8100219A/xx
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/201,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Fodder In General (AREA)
US05/402,657 1973-10-01 1973-10-01 Antiviral, substituted 1,3-dimethyl-1h-pyrazolo(3,4b)quinolines Expired - Lifetime US4013665A (en)

Priority Applications (22)

Application Number Priority Date Filing Date Title
US05/402,657 US4013665A (en) 1973-10-01 1973-10-01 Antiviral, substituted 1,3-dimethyl-1h-pyrazolo(3,4b)quinolines
FR7432265A FR2245369B1 (fi) 1973-10-01 1974-09-25
ZA00746138A ZA746138B (en) 1973-10-01 1974-09-26 Antiviral, substituted 1,3-dimethyl-1 h-pyryzolo(3,4b) quinolines
BE148952A BE820400A (fr) 1973-10-01 1974-09-26 Agents antiviraux a base de composes de la quinoline
FI2815/74A FI57414C (fi) 1973-10-01 1974-09-26 Foerfarande foer framstaellning av i 6-,7-,8- och/eller 9-staellning substituerade 4-(substituerad amino)-1,3-dimetyl-1h-pyrazolo(3,4b)kinoliner med antiviral verkan
NO743528A NO143223C (no) 1973-10-01 1974-09-27 Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,3-dimetyl-1h-pyrazol(3,4b)kinoliner
CY1087A CY1087A (en) 1973-10-01 1974-09-30 Pyrazolo(3,4,6)quinolines
GB42353/74A GB1488692A (en) 1973-10-01 1974-09-30 Pyrazolo(3,4,6)quinolines
CH1316374A CH621552A5 (fi) 1973-10-01 1974-09-30
CA210,304A CA1032538A (en) 1973-10-01 1974-09-30 Antiviral, substituted, 1,3-dimethyl-1 h-pyrazolo (3,4b) quinolines
ES430554A ES430554A1 (es) 1973-10-01 1974-09-30 Un procedimiento para la preparacion de 1,3-dimetil-1h-pira-zolo (3,4-b) quinoleinas.
SE7412275A SE419760B (sv) 1973-10-01 1974-09-30 Analogiforfarande for framstellning av antivirala substituerade 1,3-dimetyl-1h-pyrazolo (3,4-b)kinoliner
AU73798/74A AU492448B2 (en) 1974-09-30 Substituted 1,3-dimethyl-1h-pyrazolo (3, 4b) quinolines
DE19742446821 DE2446821A1 (de) 1973-10-01 1974-10-01 Substituierte 1,3-dimethyl-1hpyrazol eckige klammer auf 3,4b eckige klammer zu -chinoline
JP49112386A JPS582948B2 (ja) 1973-10-01 1974-10-01 コウウイルスセイチカン 1 3− ジメチル −1h− ピラゾロ ( 3,4d ) キノリンルイ
NL7412959A NL7412959A (nl) 1973-10-01 1974-10-01 Werkwijze voor het bereiden van gesubstitueerde imethyl-1h pyrazolo (4.3b) chinolinen.
DK516274A DK516274A (fi) 1973-10-01 1974-10-01
CH1180A CH619712A5 (fi) 1973-10-01 1980-01-03
CH484580A CH622793A5 (fi) 1973-10-01 1980-06-24
KE3086A KE3086A (en) 1973-10-01 1980-09-27 Pyrazolo(3,4,6)quinolines
HK593/80A HK59380A (en) 1973-10-01 1980-10-23 Pyrazolo (3,4,b) quinolines
MY219/81A MY8100219A (en) 1973-10-01 1981-12-30 Pyrazolo [3,4,6] quinolines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/402,657 US4013665A (en) 1973-10-01 1973-10-01 Antiviral, substituted 1,3-dimethyl-1h-pyrazolo(3,4b)quinolines

Publications (2)

Publication Number Publication Date
USB402657I5 true USB402657I5 (fi) 1976-04-06
US4013665A US4013665A (en) 1977-03-22

Family

ID=23592812

Family Applications (1)

Application Number Title Priority Date Filing Date
US05/402,657 Expired - Lifetime US4013665A (en) 1973-10-01 1973-10-01 Antiviral, substituted 1,3-dimethyl-1h-pyrazolo(3,4b)quinolines

Country Status (19)

Country Link
US (1) US4013665A (fi)
JP (1) JPS582948B2 (fi)
BE (1) BE820400A (fi)
CA (1) CA1032538A (fi)
CH (3) CH621552A5 (fi)
CY (1) CY1087A (fi)
DE (1) DE2446821A1 (fi)
DK (1) DK516274A (fi)
ES (1) ES430554A1 (fi)
FI (1) FI57414C (fi)
FR (1) FR2245369B1 (fi)
GB (1) GB1488692A (fi)
HK (1) HK59380A (fi)
KE (1) KE3086A (fi)
MY (1) MY8100219A (fi)
NL (1) NL7412959A (fi)
NO (1) NO143223C (fi)
SE (1) SE419760B (fi)
ZA (1) ZA746138B (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL73534A (en) * 1983-11-18 1990-12-23 Riker Laboratories Inc 1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
ZA848968B (en) * 1983-11-18 1986-06-25 Riker Laboratories Inc 1h-imidazo(4,5-c)quinolines and 1h-imidazo(4,5-c)quinolin-4-amines
WO1992018488A1 (fr) * 1991-04-10 1992-10-29 Japan Tobacco Inc. Nouveau derive d'oxazinone
US5608067A (en) * 1993-12-09 1997-03-04 Afonso; Adriano 4-substituted pyrazoloquinoline derivatives
US5786480A (en) * 1994-04-28 1998-07-28 Schering Corporation 4-substituted pyrazoloquinoline derivatives
US5506236A (en) * 1994-04-28 1996-04-09 Schering Corporation 4-substituted pyrazoloquinoline derivatives
US5488055A (en) * 1995-03-10 1996-01-30 Sanofi Winthrop Inc. Substituted N-cycloalkylmethyl-1H-pyrazolo(3,4-b)quinolin-4 amines and compositions and methods of use thereof
US5614530A (en) * 1995-03-10 1997-03-25 Sterling Winthrop Inc. Substituted N-arylmethyl and heterocyclmethyl-1H-pyrazolo[3,4-b]quinolin-4-amines and compositions and methods of use thereof
US6008226A (en) * 1995-03-10 1999-12-28 Sanofi-Synthelabo Substituted N-arylmethyl and heterocylylmethyl-1H-pyrazolo[3,4-b]quinolin-4-amines and compositions and methods of use thereof
AU2002352868A1 (en) * 2001-11-27 2003-06-10 Merck & Co., Inc. 4-aminoquinoline compounds
WO2003045313A2 (en) * 2001-11-27 2003-06-05 Merck & Co. Inc. 2-aminoquinoline compounds
US8080560B2 (en) 2004-12-17 2011-12-20 3M Innovative Properties Company Immune response modifier formulations containing oleic acid and methods
US8889154B2 (en) 2005-09-15 2014-11-18 Medicis Pharmaceutical Corporation Packaging for 1-(2-methylpropyl)-1H-imidazo[4,5-c] quinolin-4-amine-containing formulation
WO2008010963A2 (en) * 2006-07-18 2008-01-24 3M Innovative Properties Company Immune response modifier formulations
US8124096B2 (en) * 2006-07-31 2012-02-28 3M Innovative Properties Company Immune response modifier compositions and methods
AU2009320125A1 (en) * 2008-10-28 2010-06-03 Schering Corporation Substituted pyrazoloquinolines and derivatives thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1152421B (de) * 1961-03-21 1963-08-08 Bayer Ag Verfahren zur Herstellung von 4-Hydroxy-pyrazolo[3, 4-b]chinolinen
DE1445719A1 (de) * 1961-03-21 1969-01-09 Bayer Ag Verfahren zur Herstellung von 4-Chlor- oder 4-Brom-pyrazolo[3,4-]chinolinen
DE1186867B (de) * 1961-05-03 1965-02-11 Bayer Ag Verfahren zur Herstellung von heterocyclischen Verbindungen
DE1222885B (de) * 1962-05-25 1966-08-18 Bayer Ag Optische Aufhellungsmittel
US3600393A (en) * 1969-03-03 1971-08-17 Aldrich Chem Co Inc Dialkylamino alkylamino pyrazolo (3,4b) quinolines
JPS4826797A (fi) * 1971-08-07 1973-04-09
US3790576A (en) * 1972-03-20 1974-02-05 Parke Davis & Co 9 substituted 4,9-dihydro-1,3,4,4-tetraalkyl-1h-pyrazolo(3,4-b)quinolines

Also Published As

Publication number Publication date
KE3086A (en) 1980-11-07
MY8100219A (en) 1981-12-31
FR2245369A1 (fi) 1975-04-25
NL7412959A (nl) 1975-04-03
DK516274A (fi) 1975-06-30
JPS582948B2 (ja) 1983-01-19
HK59380A (en) 1980-10-31
CH619712A5 (fi) 1980-10-15
FI57414B (fi) 1980-04-30
NO743528L (fi) 1975-04-28
US4013665A (en) 1977-03-22
CH622793A5 (fi) 1981-04-30
GB1488692A (en) 1977-10-12
NO143223C (no) 1981-01-02
FI57414C (fi) 1980-08-11
AU7379874A (en) 1976-04-01
CY1087A (en) 1980-12-27
SE7412275L (fi) 1975-04-02
BE820400A (fr) 1975-03-26
ES430554A1 (es) 1977-07-01
ZA746138B (en) 1975-10-29
SE419760B (sv) 1981-08-24
CA1032538A (en) 1978-06-06
FI281574A (fi) 1975-04-02
FR2245369B1 (fi) 1978-07-28
CH621552A5 (fi) 1981-02-13
DE2446821A1 (de) 1975-04-10
JPS5059396A (fi) 1975-05-22
NO143223B (no) 1980-09-22

Similar Documents

Publication Publication Date Title
AU476761B2 (fi)
AU474593B2 (fi)
AU474511B2 (fi)
AU474838B2 (fi)
FR2245369B1 (fi)
AU476714B2 (fi)
AU476696B2 (fi)
AU472848B2 (fi)
AU477823B2 (fi)
AR200256A1 (fi)
AU476873B1 (fi)
AU477824B2 (fi)
AR197627A1 (fi)
AU471461B2 (fi)
BG19325A1 (fi)
AU479419A (fi)
BG19392A1 (fi)
AU479453A (fi)
BG18652A1 (fi)
BG19868A2 (fi)
AU479562A (fi)
AU479539A (fi)
AU479522A (fi)
AU479521A (fi)
AU479504A (fi)